Principal-investigator experience reaching back to the 1990s.
100+ in the last decade · 50+ in the last five years.
Real people randomized across our therapeutic areas.
Phase I–IV partnerships, kept de-identified here.
Participants randomized each year since 2015. Volume scales with the protocols open — surge years reflect large vaccine and metabolic programs.
// Bar height = participants enrolled that year · de-identified across all sponsors
// Track spans 0–200% of contracted target · dashed line marks 100% · a top-3 enroller on most studies
A mobilized, pre-screened database means FPI in under a week of greenlight.
Startup and regulatory turnaround measured in days, not months.
Proactive weekly engagement keeps participants to the final visit.
No findings across multiple FDA inspections at our Modesto site.
// Robust pre-screening keeps screen-fail rates low and data clean from visit one.
Specialists who chase compliance daily — so PRO and diary data stay complete.
Round-the-clock lines for both participants and sponsors — never a missed safety call.
Remote-monitor-ready records keep CRAs moving and queries closing fast.
Highlighted areas are where we enroll fastest and deepest. See the full menu on Capabilities.
See how we partner, what we run, and how fast we can start.